IW-9179

DRUG2 trials

Sponsors

Ironwood Pharmaceuticals, Inc.

Conditions

Diabetic GastroparesisDyspepsiaFunctional Gastrointestinal Disorders

Phase 2

Phase 2a Study of IW-9179 to Treat Functional Dyspepsia

TerminatedNCT01712412

Ironwood Pharmaceuticals, Inc.Dyspepsia, Functional Gastrointestinal Disorders

Start: 2012-10-31End: 2014-03-31Updated: 2014-03-19

Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)

CompletedNCT02289846

Ironwood Pharmaceuticals, Inc.Diabetic Gastroparesis

Start: 2014-10-31End: 2015-12-31Updated: 2016-12-05

Related Papers

Exploring the Diabetic Gastroparesis Patient Experience: Patient Exit Interviews.

2017-10-279 citations